Scientific paper - Original scientific paper
Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma
Croatian Medical Journal, 64 (2023), 2; 84-92. https://doi.org/10.3325/cmj.2023.64.84


Cite this document

Harabajsa, S., Šefčić, H., Klasić, M., Milavić, M., Židovec Lepej, S., Grgić, I. ... Korać, P. (2023). Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma. Croatian Medical Journal, 64. (2), 84-92. doi: 10.3325/cmj.2023.64.84

Harabajsa, Suzana, et al. "Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma." Croatian Medical Journal, vol. 64, no. 2, 2023, pp. 84-92. https://doi.org/10.3325/cmj.2023.64.84

Harabajsa, Suzana, Hajdi Šefčić, Marija Klasić, Marija Milavić, Snježana Židovec Lepej, Ivana Grgić, Matea Zajc Petranović, Marko Jakopović, Silvana Smojver Ježek and Petra Korać. "Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma." Croatian Medical Journal 64, no. 2 (2023): 84-92. https://doi.org/10.3325/cmj.2023.64.84

Harabajsa, S., et al. (2023) 'Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma', Croatian Medical Journal, 64(2), pp. 84-92. doi: 10.3325/cmj.2023.64.84

Harabajsa S, Šefčić H, Klasić M, Milavić M, Židovec Lepej S, Grgić I, and sur.. Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma. Croatian Medical Journal [Internet]. 2023 April [cited 2024 April 27];64(2):84-92. doi: 10.3325/cmj.2023.64.84

S. Harabajsa, et al., "Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma", Croatian Medical Journal, vol. 64, no. 2, pp. 84-92, April 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:641754. [Accessed: 27 April 2024]

Please login to the repository to save this object to your list.